Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Depisch

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
Cancer|June 22, 2000
A phase II trial of biweekly high dose gemcitabine for patients with metastatic pancreatic adenocarcinomaH Ulrich-Pur, G V Kornek, M Raderer, et al.
British Journal of Cancer|September 1, 1999
Phase II trial of gemcitabine, epirubicin and granulocyte colony-stimulating factor in patients with advanced pancreatic adenocarcinomaW Scheithauer, G V Kornek, M Raderer, et al.
British Journal of Cancer|April 17, 2003
Irinotecan plus raltitrexed vs raltitrexed alone in patients with gemcitabine-pretreated advanced pancreatic adenocarcinomaH Ulrich-Pur, M Raderer, G Verena Kornek, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2002
Biweekly high-dose gemcitabine alone or in combination with capecitabine in patients with metastatic pancreatic adenocarcinoma: a randomized phase II trialW Scheithauer, B Schüll, H Ulrich-Pur, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Fluorouracil plus racemic leucovorin versus fluorouracil combined with the pure l-isomer of leucovorin for the treatment of advanced colorectal cancer: a randomized phase III studyW Scheithauer, G Kornek, A Marczell, et al.
British Journal of Cancer|May 14, 1998
Combined intravenous and intraperitoneal chemotherapy with fluorouracil + leucovorin vs fluorouracil + levamisole for adjuvant therapy of resected colon carcinomaW Scheithauer, G V Kornek, A Marczell, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
Cancer|June 22, 2000
A phase II trial of biweekly high dose gemcitabine for patients with metastatic pancreatic adenocarcinomaH Ulrich-Pur, G V Kornek, M Raderer, et al.
British Journal of Cancer|September 1, 1999
Phase II trial of gemcitabine, epirubicin and granulocyte colony-stimulating factor in patients with advanced pancreatic adenocarcinomaW Scheithauer, G V Kornek, M Raderer, et al.
British Journal of Cancer|April 17, 2003
Irinotecan plus raltitrexed vs raltitrexed alone in patients with gemcitabine-pretreated advanced pancreatic adenocarcinomaH Ulrich-Pur, M Raderer, G Verena Kornek, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2002
Biweekly high-dose gemcitabine alone or in combination with capecitabine in patients with metastatic pancreatic adenocarcinoma: a randomized phase II trialW Scheithauer, B Schüll, H Ulrich-Pur, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Fluorouracil plus racemic leucovorin versus fluorouracil combined with the pure l-isomer of leucovorin for the treatment of advanced colorectal cancer: a randomized phase III studyW Scheithauer, G Kornek, A Marczell, et al.
British Journal of Cancer|May 14, 1998
Combined intravenous and intraperitoneal chemotherapy with fluorouracil + leucovorin vs fluorouracil + levamisole for adjuvant therapy of resected colon carcinomaW Scheithauer, G V Kornek, A Marczell, et al.
Pageof 8